- Home
- DARE vs NRT Comparison
DARE vs NRT Comparison
Compare DARE & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- NRT
- Stock Information
- Founded
- DARE N/A
- NRT 1975
- Country
- DARE United States
- NRT United States
- Employees
- DARE N/A
- NRT N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- NRT Oil & Gas Production
- Sector
- DARE Health Care
- NRT Energy
- Exchange
- DARE Nasdaq
- NRT Nasdaq
- Market Cap
- DARE 31.9M
- NRT 36.1M
- IPO Year
- DARE N/A
- NRT N/A
- Fundamental
- Price
- DARE $3.18
- NRT $3.90
- Analyst Decision
- DARE Strong Buy
- NRT
- Analyst Count
- DARE 4
- NRT 0
- Target Price
- DARE $20.33
- NRT N/A
- AVG Volume (30 Days)
- DARE 53.6K
- NRT 45.9K
- Earning Date
- DARE 11-14-2024
- NRT 02-13-2025
- Dividend Yield
- DARE N/A
- NRT 12.31%
- EPS Growth
- DARE N/A
- NRT N/A
- EPS
- DARE N/A
- NRT 0.48
- Revenue
- DARE $1,881,316.00
- NRT $5,177,424.00
- Revenue This Year
- DARE N/A
- NRT N/A
- Revenue Next Year
- DARE $136.52
- NRT N/A
- P/E Ratio
- DARE N/A
- NRT $8.21
- Revenue Growth
- DARE 88.13
- NRT N/A
- 52 Week Low
- DARE $3.05
- NRT $3.90
- 52 Week High
- DARE $7.56
- NRT $8.62
- Technical
- Relative Strength Index (RSI)
- DARE 44.72
- NRT 36.26
- Support Level
- DARE $3.18
- NRT $3.98
- Resistance Level
- DARE $3.75
- NRT $4.04
- Average True Range (ATR)
- DARE 0.15
- NRT 0.09
- MACD
- DARE 0.01
- NRT 0.02
- Stochastic Oscillator
- DARE 8.77
- NRT 0.04
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.